Dr. Harsha Rajasimha
Dr. Harsha Rajasimha is a highly respected scientist specializing in genome-based research of rare diseases and precision medicine. He has over 15 years of experience in the field of Genomics BigData analytics, systems biology, rare diseases, and precision medicine for cancer.
Dr. Rajasimha served as an affiliate faculty of systems biology and co-director of the center for the study of chronic metabolic and rare diseases at George Mason University as well as a global vice president at Strand Life Sciences (www.strandls.com).
Dr. Rajasimha led the develoment of some of the largest interdisciplinary BigData projects in Bioinformatics including PathogenPortal, Pathosystems resource integration center (funded by NIH), Cancer Biomedical Informatics Grid (caBIG funded by NCI), Cyberinfrastructure development for National Eye Institute’s genomics program (funded by NEI), laboratory information management systems (STARLIMS) implementation at the FDA Office of Regulatory Affairs, and he also architected/directed the development of Genome Explorer, an enterprise integrated platform for next-generation sequencing data analysis for Genome International Corporation. His contributions to the next-generation sequencing program at NEI were recognized by director’s innovation award in 2012.
He also founded a non-profit organization for rare diseases in India (www.ordindia.org), where he served as a board member and established mechanisms to raise awareness and accelerate rare disease diagnosis, policies, and accessibility of treatments for patients in India.
Dr. Rajasimha has authored over 15 peer-reviewed articles, book chapters, and has often been invited to be a speaker at international conferences. He has contributed to global standards initiatives such as BioPAX, DELSAGlobal, personalized medicine coalition, and the global alliance for genomics and health.
Dr. Rajasimha earned his baccalaureate degree in computer science engineering from Bangalore University, his Masters in Computer Science & Bioinformatics and his Doctoral degree in interdisciplinary program genetics, bioinformatics and computational biology from Virginia Tech.